sST2 and Big ET-1 as Alternatives of Multi-Biomarkers Strategies for Prognosis Evaluation in Patients Hospitalized with Heart Failure.

Yuyi ChenXuemei ZhaoLin LiangPengchao TianJiayu FengLiyan HuangBoping HuangYihang WuJing WangJingyuan GuanXinqing LiJian ZhangYuhui Zhang

Published in: International journal of general medicine (2023)

Multiple biomarkers in combination could provide a better prognostic value than a single biomarker. sST2 and big ET-1 could act as alternatives of multi-biomarkers strategies for prognosis evaluation beyond NT-proBNP and hs-cTnT in patients hospitalized with heart failure.

Keyphrases

heart failure
end stage renal disease
ejection fraction
newly diagnosed
machine learning
atrial fibrillation
patient reported